A former Pfizer Inc. scientist denied an allegation made by House Republicans that he conspired to delay the release of Covid ...

A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that senior executives at the pharma giant colluded to “deliberately slow down” clinical tests of its COVID-19 ...

The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...

There is positive vaccine news on the Covid-19 variant front, more emotional testimony from the Derek Chauvin trial and it's possibly the best day of the year for baseball fans. Here's what we're ...

It is true that Pfizer had scheduled the first analysis of its data after 32 of its 30,000 trial participants reported cases of COVID-19 — and thought it'd be ready before Election Day.

When the FDA released a 53-page briefing document on Pfizer’s COVID-19 mRNA vaccine candidate yesterday, most readers zeroed in on the shot’s high efficacy in a wide range of demographic groups.

Pfizer released additional data about its pill to treat COVID-19 that shows it was effective in preventing hospitalization and death when taken by people with mild to moderate illness within a few ...

Pfizer's early data shows COVID-19 vaccine is more than 90% effective 03:51. London — U.S. drugmaker Pfizer said Monday that human trials suggest its coronavirus vaccine is 90% effective at ...

Pfizer Inc and BioNTech SE on Tuesday submitted initial trial data for their COVID-19 vaccine in 5-11 year olds and said they would make a formal request to U.S. regulators for emergency use in ...

The analysis pulls on data collected from January 17 to March 6, a time in which the Pfizer and BioNTech two-dose jab was the only COVID-19 vaccine approved in Israel, and when the B.1.1.7 variant ...

Pfizer announced positive early results from its coronavirus vaccine trial, cementing the lead in a frenzied global race that has unfolded at record-breaking speed. Dr. Albert Bourla, Pfizer’s C ...